Shree Ganesh Remedies Ltd - 540737 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With regards to Audited Financial Results for the quarter and financial year ended March 31, 2021, please find enclosed herewith copies of the advertisements published as follows: a) The Indian Express (English) issue dated May 04, 2021, b) Financial Express (Gujarati) issue dated May 04, 2021. Shree Ganesh Remedies Ltd - 540737 - Corporate Action-Board approves Dividend
The Board recommended Final Dividend of Re. 1.75 / - (Rupee One and Paisa Seventy Five Only) per Equity Share of Face Value of Rs .10/- (Rupees Ten Only) each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company Shree Ganesh Remedies Ltd - 540737 - Board recommends Final Dividend
Shree Ganesh Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2021, inter alia, has recommended Final Dividend of Rs. 1.75/ - (Rupee One and Paisa Seventy Five Only) per Equity Share of Face Value of Rs. 10/- (Rupees Ten Only) each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company. Shree Ganesh Remedies Ltd - 540737 - Financial Results For The Quarter And Financial Year Ended March 31, 2021.
Financial Results for the Quarter and Financial Year ended March 31, 2021. Shree Ganesh Remedies Ltd - 540737 - Outcome Of Board Meeting
Outcome of Board Meeting for: 1. Audited Financial Results for the quarter and Financial year ended March 31, 2021, 2. Recommendation of Final Dividend for the Financial Year 2020-21. Shree Ganesh Remedies Ltd - 540737 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShree Ganesh Remedies Ltd 2CINL24230GJ1995PLC025661 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.21 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ADITYA VIKRAMBHAI PATEL Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: investors@ganeshremedies.com Name of the Chief Financial Officer: SURESHBHAI DALSUKHBHAI PANCHAL Designation: CHIEF FINANCIAL OFFICER EmailId: cfo@ganeshremedies.com Date: 30/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Shree Ganesh Remedies Ltd - 540737 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Babubhai Manubhai Kothia, Gunjan Chandubhai Kothia, Hasmukhbhai Manubhai Kothia, Manjulaben Hasmukhbhai Kothia, Pratibhaben Ketanbhai Kothia, Chandulal Manubhai Kothia & Hanshaben Chandubhai Kothia Shree Ganesh Remedies Ltd - 540737 - Shareholding for the Period Ended March 31, 2021
Shree Ganesh Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here Shree Ganesh Remedies Ltd - 540737 - Board to consider Final Dividend
Shree Ganesh Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 03, 2021, to consider amongst other business, inter-alia, the following:1. Approval of Audited Financial Results of the Company for the qu arter and financial year ended on March 31, 2021.2. Recommendation of Final Dividend on the Equity Shares, if any.In accordance to the Code of Conduct of the Company for prohibition of insider trading, th e "Trading Window" for dealing / trading in the shares of the Company was closed from April 01, 2021 and shall remain closed till 48 hours from the closure of the Board Meeting.